How Cannabis and Psilocybin Might Help Some of the 50 Million Americans Who Are Experiencing Chronic Pain

Cannabis Culture
By The ConversationMay 10, 2024, 6:16 pm464 ptsTop
The U.S. Drug Enforcement Agency announced in late April 2024 that it plans to ease federal restrictions on cannabis, reclassifying it from a Schedule I drug to the less restricted Schedule III, which includes drugs such as Tylenol with codeine, testosterone and other anabolic steroids. This historic shift…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Chicago Police Can’t Search Vehicles Based on Smell of Raw Cannabis Under New Rules 68

Half-Year Retrospective: What Has Worked and What Hasn’t in Cannabis 68

Nebraska Medical Cannabis Commission Proposal Will ‘Destroy Patient Access,’ Advocates Say 68

Nova Scotians bought $127 worth of cannabis in 2024 as sales begin to level off 67

The PFAS Threat in Cannabis and Hemp: What You Need to Know 62

Circuit Court Ruling for Arkansas Renders Texas Governor’s Hemp Veto Argument Moot 62

World-Class Growing Solutions 59

Science, Not Politics, Must Guide Hemp’s Regulatory Future 58

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.